Research Papers:
A small deletion in SERPINC1 causes type I antithrombin deficiency by promoting endoplasmic reticulum stress
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1647 views | HTML 2110 views | ?
Abstract
Jingjing Su1,*, Liang Shu1,*, Zhou Zhang2,*, Lei Cai3, Xin Zhang1, Yu Zhai1, Jianren Liu1,4
1Department of Neurology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China
2Institute of Biliary Tract Disease Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
3Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Key Laboratory of Psychotic Disorders (No.13dz2260500), Shanghai Jiao Tong University, Shanghai 200240, China
4Clinical Research Center of Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
*These authors have contributed equally to this work as co-first authors
Correspondence to:
Jianren Liu, email: [email protected]
Yu Zhai, email: [email protected]
Keywords: SERPINC1, deletion mutation, antithrombin deficiency, endoplasmic reticulum stress
Received: April 23, 2016 Accepted: September 20, 2016 Published: September 30, 2016
ABSTRACT
Antithrombin (AT) deficiency is an autosomal dominant disorder, and identification of mutation AT variants would improve our understanding of the anticoagulant function of this serine protease inhibitor (SERPIN) and the molecular pathways underlying this disorder. In the present study, we performed whole-exome sequencing of a Chinese family with deep vein thrombosis, and identified a new small deletion that eliminates four amino acids (INEL) from exon 4 of SERPINC1 gene. This causes type I AT deficiency by enhancing the intracellular retention of this protein. AT retention leads to endoplasmic reticulum (ER) stress, which further inhibits AT release. In addition, ER stress activates ER-associated degradation, which promotes AT degradation. Suppression of ER stress enhanced the secretion of AT, while inhibition of ER-associated degradation suppressed AT release. Thus, our study identified a new mutation (INEL deletion) causing type I AT deficiency, and uncovered a novel mechanism for AT retention through enhanced ER stress, which may provide an innovative approach for treating AT deficiency.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 12349